XENETIC BIOSCIENCES, INC. Operating Leases, Future Minimum Payments, Due in Two Years
XENETIC BIOSCIENCES, INC. (XBIO) had Operating Leases, Future Minimum Payments, Due in Two Years of $0 as of 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-03-29
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $0.00.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $106.56K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $102.60K.
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $98.64K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-29 |
| 2016-12-31 | $106.56K 10-K · filed 2017-03-31 |
| 2015-12-31 | $102.60K 10-K · filed 2016-03-30 |
| 2014-12-31 | $98.64K 10-K · filed 2015-04-15 |
| 2013-12-31 | $148.71K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |